Directive 1965/65 - Approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products

Please note

This page contains a limited version of this dossier in the EU Monitor.

1.

Current status

This directive was in effect from February  3, 1965 until December 17, 2001 and should have been implemented in national regulation on December 31, 1966 at the latest.

2.

Key information

official title

Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products
 
Legal instrument Directive
Number legal act Directive 1965/65
CELEX number i 31965L0065

3.

Key dates

Document 26-01-1965
Publication in Official Journal 09-02-1965; Special edition in Greek: Chapter 13 Volume 001,Special edition in Danish: Chapter I Volume 1965-1966,Special edition in Swedish: Chapter 13 Volume 001,Special edition in English: Chapter I Volume 1965-1966,Special edition in Portuguese: Chapter 13 Volume 001,Special edition in Finnish: Chapter 13 Volume 001,OJ P 22, 9.2.1965,Special edition in Spanish: Chapter 13 Volume 001
Effect 03-02-1965; Entry into force Date notif.
End of validity 17-12-2001; Repealed by 32001L0083
Transposition 31-12-1966; See Art 22 ET 366L0454 Art 1
03-02-1970; See Art 24
Notification 03-02-1965

4.

Legislative text

Avis juridique important

|

5.

31965L0065

Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products

Official Journal 022 , 09/02/1965 P. 0369 - 0373

Finnish special edition: Chapter 13 Volume 1 P. 0067

Swedish special edition: Chapter 13 Volume 1 P. 0067

Danish special edition: Series I Chapter 1965-1966 P. 0017

English special edition: Series I Chapter 1965-1966 P. 0024

Greek special edition: Chapter 13 Volume 1 P. 0025

Spanish special edition: Chapter 13 Volume 1 P. 0018

Portuguese special edition Chapter 13 Volume 1 P. 0018

COUNCIL DIRECTIVE of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products (65/65/EEC)

THE COUNCIL OF THE EUROPEAN ECONOMIC COMMUNITY,

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;

Having regard to the proposal from the Commission;

Having regard to the Opinion of the European Parliament (1);

Having regard to the Opinion of the Economic and Social Committee (2);

Whereas the primary purpose of any rules concerning the production and distribution of proprietary medicinal products must be to safeguard public health;

Whereas, however, this objective must be attained by means which will not hinder the development of the pharmaceutical industry or trade in medicinal products within the Community;

Whereas trade in proprietary medicinal products within the Community is hindered by disparities between certain national provisions, in particular between provisions relating to medicinal products (excluding substances or combinations of substances which are foods, animal feeding-stuffs or toilet preparations) ; and whereas such disparities directly affect the establishment and functioning of the common market;

Whereas such hindrances must accordingly be removed ; and whereas this entails approximation of the relevant provisions;

Whereas, however, such approximation can only be achieved progressively ; and whereas priority must be given to eliminating the disparities liable to have the greatest effect on the functioning of the common market;

HAS ADOPTED THIS DIRECTIVE:

CHAPTER I Definitions and scope

Article 1

For the purposes of this Directive, the following shall have the meanings hereby assigned to them; 1. Proprietary medicinal product:

Any ready-prepared medicinal product placed on the market under a special name and in a special pack.

  • 2. 
    Medicinal product:

Any substance or combination of substances presented for treating or preventing disease in human beings or animals.

Any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in human beings or in animals is likewise considered a medicinal product.

  • (1) 
    OJ No 84, 4.6.1963, p. 1571/63. (2) OJ No 158, 16.10.1964, p. 2508/64. 3. Substance:

Any matter irrespective of origin which may be: - human, e.g.

human blood and human blood products;

  • animal, e.g.

micro-organisms, whole animals, parts of organs, animal secretions, toxins, extracts, blood products, etc;

  • vegetable, e.g.

micro-organisms, plants, parts of plants, vegetable secretions, extracts, etc;

  • chemical, e.g.

elements, naturally occurring chemical materials and chemical products obtained by chemical change or synthesis.

Article 2

The provisions of Chapters II to V shall apply only to proprietary medicinal products for human use intended to be placed on the market in Member States.

CHAPTER II Authorisation to place proprietary medicinal products on the market

Article 3

No proprietary medicinal product may be placed on the market in a Member State unless an...


More

This text has been adopted from EUR-Lex.

 

6.

Sources and disclaimer

For further information you may want to consult the following sources that have been used to compile this dossier:

This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.

 

7.

Full version

This page is also available in a full version containing the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and the related cases of the European Court of Justice.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

8.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.